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Androgen-independent prostate carcinomas are resistant to chemotherapy and cell lines derived from androgen-independent
prostate carcinomas such as DU 145 cells are highly resistant to Fas-mediated apoptosis. The incubation of DU 145 cells with anti-Fas
IgM agonistic antibody of Fas receptor fails to activate JNK, a stress kinase involved in regulating apoptosis. We have previously shown
that JNK activation is sufficient and necessary to promote Fas-mediated apoptosis in DU 145 cells. We investigate the mechanisms by
which JNK activation and apoptosis are abrogated. HSP27 is overexpressed in DU 145 cells and has previously been reported to
sequester DAXX and prevent JNK activation in cells treated with anti-Fas IgM. However, we find no evidence that HSP27 interacts
with DAXX in DU 145 cells. Instead, we find that FADD does not interact with caspase-8 and this results in defective death-inducing
signalling complex formation following Fas receptor activation.
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Prostate cancer is the second most common malignancy in the EU,
with about 200000 new cases diagnosed each year. It is a disease
that affects primarily elderly men and is responsible for over
35000 deaths each year (Parkin et al, 2001). Androgen-dependent
prostate cancer is generally a slowly progressing tumour and
treatment with androgen ablation therapy results in tumour
regression and an improvement in the quality of life for most
patients. However, androgen refractory tumours subsequently
develop with a median asymptomatic period of 18 months
following androgen ablation (Petrylak, 1999). Androgen-indepen-
dent tumours are generally more aggressive than androgen-
dependent tumours and chemotherapy is only used as a palliative
agent (Sternberg, 2001). No single or combined chemotherapeutic
regimen has been shown to enhance long-term survival signifi-
cantly in patients presenting with invasive, hormone refractory
prostate cancer (Petrylak, 1999).
The Fas apoptotic pathway has been extensively studied in a
variety of tissues and cell types. Tumour cells often develop
resistance to Fas receptor-mediated apoptosis as a defence
mechanism against the immune system and also against conven-
tional chemotherapeutic agents (Micheau et al, 1999; O’Connell
et al, 2001). Engagement of Fas receptor with Fas ligand or Fas-
activating antibodies causes recruitment of procaspase-8 to the
death-inducing signalling complex (DISC) through the adapter
protein FADD in cell lines sensitive to Fas receptor-mediated
apoptosis. Autocleavage and activation of caspase-8 occurs in the
DISC and this in turn cleaves a variety of cellular targets,
culminating in caspase-3 cleavage and apoptosis (Boldin et al,
1996; Muzio et al, 1996).
Engagement of Fas receptor with Fas ligand also results in the
recruitment of a variety of proteins not directly involved in
caspase-8 recruitment and cleavage. These proteins are responsible
for initiating other signal transduction pathways from Fas
receptor. One protein recruited to the DISC following Fas receptor
activation is DAXX, normally present in the nucleus of cells. DAXX
binds to Fas receptor at a different site to FADD and is responsible
for the recruitment and activation of the kinase ASK1. ASK1 in
turn activates the MAPK cascade resulting in JNK activation
(Chang et al, 1998; Tobiume et al, 2001). JNK can also be activated
by a caspase-8-dependent mechanism involving cleavage of Mst1
(Graves et al, 2001) or MEKK1 (Deak et al, 1998), and JNK
activation has been reported to enhance Fas receptor-mediated
apoptosis in some cell lines (Brenner et al, 1997; Yang et al, 1997;
Le-Niculescu et al, 1999; Costa-Pereira et al, 2000; Zhang et al,
2000).
Upregulation of heat-shock transcription factor-1 was reported
to occur in metastatic prostate cancer cell lines. This results in
increased expression of HSP27 (Hoang et al, 2000), and is
invariably associated with poor clinical outcome in patients with
advanced prostate cancer (Cornford et al, 2000). HSP27 can
protect cells from a variety of apoptotic insults including Fas-
mediated apoptosis and various chemotherapeutic drugs (Mehlen
et al, 1996; Samali and Cotter, 1996) by sequestering cytochrome c
after it is released from the mitochondria and preventing caspase-9
activation (Garrido et al, 1999). It can also prevent cytochrome c
release by inhibiting Bid translocation to the mitochondrion (Paul
et al, 2002). HSP27 can bind to and prevent the translocation of
DAXX to the plasma membrane following Fas receptor activation,
thus inhibiting JNK activation and the proapoptotic function
associated with DAXX (Charette et al, 2000).
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mediated apoptosis. This resistance can be overcome by coadmi-
nistering sublethal concentrations of various chemotherapeutic
drugs (Rokhlin et al, 1997; Costa-Pereira and Cotter, 1999). Our
group has previously demonstrated that JNK activation is
sufficient to sensitise DU 145 cells to Fas receptor-mediated
apoptosis (Costa-Pereira et al, 2000; Curtin and Cotter, 2002).
However, we found that engagement of Fas receptor with Fas-
activating antibodies could not activate JNK in DU 145 cells. In
order to understand the mechanism by which DU 145 cells are
resistant to Fas, we explored the events inhibiting JNK activation.
We found that DAXX did not translocate from the nucleus to the
cytoplasm following stimulation of Fas. Although HSP27 was
highly overexpressed, it did not appear to play a role in this
process by sequestering DAXX. Procaspase-8 was not cleaved
following Fas receptor activation and further investigation
demonstrated that defective DISC formation was the underlying
cause by which Fas receptor activation failed to activate either JNK
or caspase-8.
MATERIALS AND METHODS
Cell lines and reagents DU 145 and Jurkat T cells were obtained
from American Type Culture Collection (ATCC, Rockville, MD,
USA). Cell culture reagents were purchased from Sigma (UK). The
fluorescent probes used to detect apoptosis were FITC-conjugated
Annexin V (IQ Products, The Netherlands) and propidium iodide
(PI) (Sigma, UK). SB203580 and z-VAD-fmk were purchased from
Calbiochem (UK). The antibodies used in this study were Fas-
activating mouse anti-Fas IgM clone CH-11 and rabbit anti-FADD
(Upstate Biotechnology, UK), mouse anti-Fas IgG (Bender Med
Systems, Silverstone, Towcester, UK), phospho-JNK (Thr183/Tyr185)
clone G9 and mouse anti-caspase-8 (Cell Signalling Technology,
UK), rabbit anti-JNK1 and rabbit anti-DAXX (Santa Cruz, USA),
mouse anti-PARP (PharMingen, BD Biosciences, UK), mouse anti-
HSP27 (Stressgen, UK) and mouse anti-actin (Sigma, UK). The
HRP-labelled anti-rabbit IgG and anti-mouse IgG antibodies were
obtained from DAKO (Denmark), while FITC-conjugated anti-
rabbit IgG was purchased from Sigma (UK). Protein G–agarose
slurry was obtained from Peirce (UK) and all other reagents were
obtained from Sigma (UK). Anti-Fas IgM was stored at 10mgml
1
in PBS at 201C, SB203580 was stored at 5mM in DMSO at 201C
and z-VAD-fmk was stored at 25mM in DMSO at 201C.
Cell culture
DU 145 cells were cultured in RPMI 1640 medium supplemented
with 5% FCS, 2mML -glutamine and 10IUml
1 penicillin–
streptomycin. Jurkat cells were cultured in RPMI 1640 medium
containing 10% FCS, 2mML -glutamine and 10IUml
1 penicillin–
streptomycin. Cells were cultured at 371C in a humidified
atmosphere with 5% CO2 and were routinely subcultured every
2–3 days. DU 145 cells were grown to 75% confluency and Jurkat
cells were resuspended in fresh media at 0.510
6ml
1 on the day
of each experiment. Cells were incubated with 200ngml
1 anti-Fas
IgM for 1, 4 or 24h and pretreated for 1h with 25mM z-VAD-fmk
or 5mM SB203580, as indicated in the figure legends.
Fas receptor expression
A total of 0.510
6 cells were used per sample and were harvested
and washed twice in PBS. They were stained for 1h at 41C with
20mgml
1 of mouse anti-Fas IgG (1/50). After another two washes
with PBS, the cells were stained with the FITC-conjugated sheep
anti-mouse IgG (1/40) for 1h at 41C in the dark. Cells stained with
secondary antibody alone were used to compensate for intrinsic
fluorescence and nonspecific binding of the secondary antibody.
The samples were read on a FACScan flow cytometer and the data
were analysed using Cell Quest software (Beckton Dickenson, UK).
Annexin V binding and PI uptake assay
DU 145 and Jurkat cells were incubated with 200ngml
1 anti-Fas
IgM for 4 and 24h as indicated. The cells were subsequently
harvested, washed once in PBS and resuspended in 200ml Annexin
V binding buffer (150mM NaCl, 18mM CaCl2,1 0m M HEPES, 5mM
KCl, 1mM MgCl2). A measure of 1mgml
1 FITC-conjugated
Annexin V, which binds specifically to external phosphatidyl
serine on apoptotic cells, was added to each sample and incubated
at room temperature for 5min. PI (50mgml
1) was added
immediately prior to reading the samples on the FACScan. Viable
cells exclude PI and stain negative on FL-2. Apoptotic cells are
labelled with Annexin V and stain positive on FL-1. Analysis was
carried out using Cell Quest Software.
SDS–PAGE and Western blot
Protein extracts were prepared from cells using RIPA lysis buffer
(50mM Tris, pH 7.4, 150mM NaCl, 1mM each of NaF, NaVO4 and
EGTA, 1% NP40, 0.25% sodium deoxycholate, 0.2mM phenyl-
methylsulphonyl fluoride, 1mgml
1 each of antipain, aprotinin
and chymostatin, 0.1mgml
1 leupeptin, 4.0mgml
1 pepstatin) and
30mg of protein in 20ml SDS–polyacrylamide gel (PAGE) loading
dye was loaded in each lane of a 12% SDS–PAGE. Electrophoresis
and Western blotting was subsequently carried out. Non-specific
protein binding sites were blocked and the membrane was stained
with primary and peroxidase-conjugated secondary antibodies
according to the manufacturer’s recommended protocol. Labelled
protein was detected using ECL (Amarsham, UK).
Immunofluorescent staining of DAXX
DU 145 cells were seeded on glass coverslips and grown to
confluency over 48h. They were incubated with 200ngml
1 anti-
Fas IgM for 4h or left untreated. The media were aspirated and the
coverslips were washed in PBS. The cells were fixed for 15min at
room temperature in 3% PFA in PBS. They were washed in PBS
and incubated for 15min at room temperature in quenching buffer
(50mM NH4CL in PBS). Cells were permeabilised with 0.1% Triton
X-100 in PBS for 5min at room temperature and washed in PBS
before incubating with primary antibody (1:100 in PBS) with 5%
FCS for 1h at room temperature. The primary antibody was
aspirated off and the cells were washed in PBS before incubating
for 1h at room temperature in FITC-conjugated secondary
antibody (1:80 in PBS) with DAPI and 5% FCS. Cells were then
washed in PBS and mounted on glass slides.
Isolation of nuclear- and cytoplasmic-enriched fractions
A minimum of 510
6 cells were incubated with 200ngml
1 anti-
Fas IgM for 4h. The cells were harvested and resuspended in 250ml
homogenising buffer (210mM mannitol, 70mM sucrose, 5mM
HEPES, 1mM EGTA, 0.5% BSA, 1mM DTT, 0.2mM PMSF,
5mgml
1 each of antipain, aprotinin and chymostatin, 0.5mgml
1
leupeptin, 20mgml
1 pepstatin). The sample was then transferred
to a 2ml tissue grinding tube (Kontes Glass Company, NJ, USA)
and homogenised with 100 strokes of the low clearance pestle. The
homogenate was centrifuged at 3000g for 5min. The supernatant
(cytoplasmic fraction) was washed three times at 3000g. The pellet
(nuclear fraction) was washed three times in PBS, and the protein
extract was prepared using RIPA lysis buffer. SDS–PAGE and
Western blotting were performed as described previously.
Defective DISC formation in DU 145 cells
JF Curtin and TG Cotter
1951
British Journal of Cancer (2003) 89(10), 1950–1957 & 2003 Cancer Research UK
M
o
l
e
c
u
l
a
r
a
n
d
C
e
l
l
u
l
a
r
P
a
t
h
o
l
o
g
yImmunoprecipitation
A minimum of 500mg of protein was used per sample. DU 145 cells
were treated and harvested as described in the figure legends. The
cells were gently lysed on ice in lysis buffer (10mM Tris pH 7.5,
50mM NaCl, 10mM sodium pyrophosphate, 50mM NaF, 1mM
NaVO4, 1% NP40, 0.2mM PMSF, 5mgml
1 each of antipain,
aprotinin and chymostatin, 0.5mgml
1 leupeptin, 20mgml
1
pepstatin) and centrifuged at 20000g for 15min to remove
insoluble material. The total cell protein was quantitated and
diluted to 1mgml
1 in PBS. Protease inhibitors were added
(1mgml
1 each of antipain, aprotinin and chymostatin, 0.1mgml
1
leupeptin, 4mgml
1 pepstatin), and the samples were incubated
with 10mgml
1 rabbit anti-DAXX or 10mgml
1 rabbit anti-FADD
overnight at 41C. Protein G–agarose-conjugated beads were
prepared according to the manufacturer’s recommended instruc-
tions and incubated with the samples for a further 1h at 41C.
DAXX was immunoprecipitated from total protein by centrifuga-
tion at 1000g for 3min. The beads were washed four times in PBS
and boiled in SDS–PAGE loading buffer for 5min. The agarose
beads were precipitated out of solution by centrifugation at
20000g for 2min and the supernatant was loaded onto an SDS–
PAGE and analysed by Western blot as described previously.
RESULTS
DU 145 prostate carcinoma cells are resistant to
Fas-mediated apoptosis
Flow cytometry was used to determine the expression of cell
surface Fas receptor in DU 145 cells and Jurkat T cells. We found
that the expression of Fas receptor was comparable between the
two cell lines (Figure 1A). However, the sensitivity of these two cell
lines to Fas-mediated apoptosis was found to be markedly
different. Using Annexin V–FITC to detect cells at early stages
in apoptosis, Jurkat cells were found to undergo extensive
apoptosis in less than 4h following incubation with 200ngml
1
anti-Fas IgM. By contrast, no increase in apoptosis was observed in
DU 145 cells treated with 200ngml
1 anti-Fas IgM even for 24h
(Figure 1B). Morphological assessment of apoptosis was used to
confirm this observation (data not shown). JNK activation has
been reported to accompany Fas receptor activation. Some studies
found that JNK was not required for Fas receptor-mediated
apoptosis (Abreu-Martin et al, 1999; Low et al, 1999; Hofmann
et al, 2001), but others have shown that JNK activation accelerates
Fas-mediated apoptosis in a number of cell lines (Brenner et al,
1997; Yang et al, 1997; Le-Niculescu et al, 1999; Zhang et al, 2000).
Our group has previously identified JNK activation as being
necessary for Fas-mediated apoptosis in DU 145 cells (Costa-
Pereira et al, 2000; Curtin and Cotter, 2002). As a result, we
determined the extent of JNK activation in DU 145 cells and Jurkat
cells following incubation with 200ngml
1 anti-Fas IgM for 1 and
4h. We found that JNK was only extensively phosphorylated in
Jurkat cells treated for 4h with anti-Fas IgM (Figure 1C). No
increase in JNK phosphorylation was observed in DU 145 cells
even after 24h (data not shown).
DAXX is expressed in the nucleus of DU 145 cells
Fas receptor is believed to activate JNK by caspase-dependent and
-independent mechanisms. The activation of Fas receptor can
recruit DAXX, a nuclear protein, to the plasma membrane during
DISC formation. DAXX subsequently binds to and activates ASK1,
an upstream kinase in the JNK signalling pathway (Chang et al,
1998; Tobiume et al, 2001). Immunofluorescence was used to
determine DAXX subcellular localisation in DU 145 cells. We
found that DAXX was predominately located in the nucleus of DU
145 cells and the staining pattern appeared to be punctated. This is
in agreement with other reports that localised DAXX to ND-10
domains in the nucleus (Torii et al, 1999; Charette et al, 2000). No
change in DAXX subcellular localisation was observed following
incubation for 4h with 200ngml
1 anti-Fas IgM (Figure 2A). The
expression of DAXX was also determined in nuclear- and
cytoplasmic-enriched fractions by Western blot. No increase in
cytoplasmic DAXX was identified in cells incubated with
200ngml
1 anti-Fas IgM for 4h, confirming the immunofluores-
cence data (Figure 2B). We also assessed the extent of DAXX
translocation after 8 and 24h incubation with anti-Fas IgM and did
not observe any increase in the cytoplasmic fraction of DAXX
(data not shown).
HSP27 is overexpressed in DU 145 cells but does not
interact with DAXX
HSP27 has previously been found to bind and inhibit DAXX
translocation and apoptosis in response to Fas receptor activation
(Charette et al, 2000). In addition, the overexpression of HSP27
correlates with prostate cancer progression (Cornford et al, 2000).
Therefore, we analysed whether HSP27 inhibited JNK activation
following Fas receptor activation in DU 145 cells. HSP27
expression was determined in nuclear- and cytoplasmic-enriched
fractions from DU 145 cells and Jurkat cells. We found that HSP27
was highly overexpressed in DU 145 cells and was predominantly
located in cytoplasmic-enriched fractions. No change in subcel-
lular expression was observed following treatment with
200ngml
1 anti-Fas IgM for 4h (Figure 3A). Although HSP27 is
expressed mainly in the cytoplasm and DAXX is present primarily
in the nucleus, it is possible that the cytoplasmic DAXX is
important for binding Fas receptor or that HSP27 prevents
recruitment of nuclear DAXX to the Fas DISC. As a result, we
immunoprecipitated DAXX from cell lysates of DU 145 cells
incubated for 4h with 200ngml
1 anti-Fas IgM or left untreated.
We could not detect any HSP27 expressed in the immunopreci-
pitate, suggesting that either HSP27 and DAXX do not interact in
DU 145 cells or the percentage HSP27 that interacts with DAXX is
extremely small in comparison with total HSP27 expression in
these cells (Figure 3B). It was reported that endogenous P38
activity maintained HSP27 in active dimers. The inhibition of P38
resulted in multimeric complexes of HSP27 and this abrogated the
interaction between HSP27 and DAXX. In addition, SB203580
sensitised cells to Fas receptor-mediated apoptosis by allowing
DAXX translocation from the nucleus to the cytoplasm (Charette
et al, 2000). We did not observe any increase in cytoplasmic DAXX
(data not shown) or increase in apoptosis in cells preincubated
with SB203580 (Figure 3C). This supports our conclusion that
HSP27 does not prevent DAXX translocation and JNK activation in
DU 145 cells.
Fas-mediated caspase activation is required for JNK
activation in Jurkat cells but is defective in DU 145 cells
In order to study caspase-dependent JNK activation, we incubated
DU 145 and Jurkat cells with 200ngml
1 anti-Fas IgM in the
presence and absence of the general caspase inhibitor z-VAD-fmk
for 4h. Cleavage of procaspase-8 was subsequently assessed by
Western blot analysis. We found that procaspase-8 was extensively
cleaved into the intermediate P41/P43 products and active P18
subunit only in Jurkat cells following incubation with 200ngml
1
anti-Fas IgM. Z-VAD-fmk was found to abrogate the cleavage of
caspase-8 completely. Procaspase-8 was not cleaved following
treatment of DU 145 cells with 200ngml
1 anti-Fas IgM. This
indicates that inhibition of Fas-mediated apoptosis is an early
event in these cells, possibly during DISC formation (Figure 4A).
The effect of caspase inhibition on JNK activation was also
assessed in Jurkat cells. Z-VAD-fmk was found to abrogate JNK
activation completely in Jurkat cells following incubation with
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1 anti-Fas IgM. This suggests that in this cell line, the
principle mechanism of JNK activation is caspase dependent
(Figure 4B).
DISC formation following Fas receptor activation is
defective in DU 145 cells
Although cell surface Fas receptor expression is similar in DU 145
and Jurkat cells, we found that neither JNK nor caspase-8 are
activated in DU 145 cells. This may be due to defective DISC
formation following Fas receptor activation in DU 145 cells. We
immunoprecipitated FADD from cells before and after incubation
with 200ngml
1 anti-Fas IgM for 1h. The expression of caspase-8
was assessed in these immunoprecipitates to determine the extent
of FADD-caspase-8 aggregation in the DISC. While FADD was
found to associate with caspase-8 in Jurkat cells incubated with
anti-Fas IgM, no interaction was evident in DU 145 cells (Figure 5).
These data suggest that the interaction between caspase-8 and
FADD is defective and prevents DISC formation following Fas
receptor activation in DU 145 cells. This appears to be the
principle mechanism by which DU 145 cells are resistant to anti-
Fas IgM, and also why JNK is not activated in these cells.
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Figure 1 DU 145 cells express Fas receptor at the plasma membrane but are highly resistant to Fas-induced apoptosis. (A) Cell surface expression of Fas
receptor (–) was assessed in DU 145 cells and Jurkat cells as described in the Materials and Methods section. Intrinsic fluorescence of cells labelled with
secondary antibody alone (—) is also shown. Data are representative of three independent experiments. (B) Jurkat cells were incubated for 4h and DU 145
cells were incubated for 4 and 24h with 200ngml
1 anti-Fas IgM. Apoptosis was subsequently determined by staining with Annexin V–FITC and PI. The
percentage of apoptotic cells is shown in the bottom right quadrant of each plot. Data are representative of three independent experiments. (C)
Phosphorylation of JNK at residues Thr 183 and Tyr 185 was assessed in DU 145 cells and Jurkat cells following treatment with 200ngml
1 anti-Fas IgM for
1 and 4h where indicated. The total JNK expression was also determined to demonstrate equal protein loading.
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The activation of the Fas receptor in cells by Fas ligand results in
caspase activation and morphological apoptosis in a variety of cell
lines. Fas receptor plays a critical role in the homeostasis of the
immune system and may be involved in immune surveillance and
clearance of defective cells (Pinkoski and Green, 2000; O’Connell
et al, 2001). Although the events initiated by Fas receptor
culminating in caspase activation and apoptosis are well under-
stood, the mechanisms by which tumour cells alter signalling
pathways and become resistant to Fas-mediated apoptosis are not.
DU 145 cells are androgen-independent prostate carcinoma cells
and are resistant to a variety of chemotherapeutic drugs in vitro.
We found that while cell surface expression of Fas receptor was
comparable to Jurkat cells, DU 145 cells were highly resistant to
Fas-mediated apoptosis. The activation of JNK using chemother-
apeutic drugs or anisomycin was sufficient to sensitise these cells
to Fas (Costa-Pereira and Cotter, 1999; Costa-Pereira et al, 2000;
Curtin and Cotter, 2002).
JNK activation has been reported to accompany Fas receptor
activation and appears to be involved in regulating Fas-mediated
apoptosis in various cell lines. While JNK is not proapoptotic in
every cell line, it appears that certain cell lines resistant to Fas-
mediated apoptosis require JNK activation to promote apoptosis.
We found that the treatment of DU 145 cells with anti-Fas IgM
alone did not stimulate JNK activation. In order to better
understand the resistance of DU 145 cells to Fas-mediated
apoptosis, we investigated JNK activation following Fas receptor
stimulation in DU 145 cells. JNK activation following Fas receptor
activation may be caspase-8 dependent or caspase-8 independent.
During caspase-8-independent JNK activation, DAXX is recruited
to the plasma membrane and binds to the intracellular C-terminus
of Fas receptor independent of FADD. ASK1, a JNK kinase kinase
is recruited to the plasma membrane and binds to DAXX. The
activation of ASK1 in trans results in MKK4/JNKK1 phosphoryla-
tion and ultimately JNK phosphorylation at Thr183/Tyr185 and
activation (Tobiume et al, 2001). DU 145 cells were found to
express DAXX predominantly in ND-10 domains in the nucleus
and this is consistent with previous reports (Torii et al, 1999;
Charette et al, 2000). We found that a small fraction of DAXX was
present in the cytoplasmic fraction, although the levels of
cytoplasmic DAXX were not found to increase following Fas
receptor activation. In addition, no clustering of DAXX at the
plasma membrane was evident in cells treated with anti-Fas IgM.
HSP27 overexpression has been associated with prostate cancer
progression and can independently predict the clinical outcome of
prostate cancer, suggesting that it plays an important role in the
resistance of prostate cancer to chemotherapy (Thomas et al, 1996;
Cornford et al, 2000). HSP27 inhibits apoptosis by a variety of
mechanisms, including sequestering cytosolic proapoptotic Cyto-
-DaXX FITC
DAPI
Untreated -Fas IgM 4h
NC N
DAXX
PARP
Anti-Fas IgM
fraction
+ + − −
C
A
B
Figure 2 DAXX expression and subcellular localisation in DU 145 cells. (A) Immunofluorescent analysis of DAXX was performed on DU 145 cells
incubated for 4h with 200ngml
1 anti-Fas IgM. Samples were counterstained with DAPI to visualise the nuclei of cells. (B) Western blot analysis of DAXX
expression in nuclear- and cytoplasmic-enriched fractions obtained from DU 145 cells incubated for 4h with 200ngml
1 anti-Fas IgM or without. PARP was
also stained to assess the purity of the fractions.
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ychrome c, inhibiting proapoptotic tBID translocation from cytosol
to the mitochondrion and preventing DAXX association with Fas
receptor and subsequent JNK activation (Concannon et al, 2003).
We found that DU 145 cells overexpress HSP27 and is
predominantly found in the cytoplasmic fraction. A small fraction
present in the nucleus was also evident. However, we could not
identify any physical interaction between HSP27 and DAXX in DU
145 cells either before or after Fas receptor activation. This
suggests that it is not involved in regulating DISC formation and
JNK activation in DU 145 cells. It is likely that HSP27 regulates the
sensitivity of mitochondria to apoptosis signals and can prevent
cytochrome c release in response to cytotoxic drugs because HSP27
overexpression correlates with poor clinical outcome (Cornford
et al, 2000). However, another mechanism inhibits Fas receptor-
mediated apoptosis and JNK activation in DU 145 cells.
Caspase-8 activation results in the cleavage and constitutive
activation of MEKK1 and Mst1, kinases that can phosphorylate
and activate JNK. We found that caspase-8 is expressed at similar
levels in DU 145 cells and Jurkat cells, but Fas receptor engagement
with Fas-activating antibodies was found only to cleave procas-
pase-8 into active fragments in Jurkat cells. This cleavage could be
completely abrogated using z-VAD-fmk, an irreversible caspase
inhibitor. JNK phosphorylation was also completely inhibited in
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Figure 3 HSP27 is overexpressed in DU 145 cells, but is localised
predominantly in the cytoplasm and does not coimmunoprecipitate with
DAXX. (A) Expression of HSP27 was analysed in nuclear- and
cytoplasmic-enriched fractions isolated from DU 145 cells and Jurkat cells
before and after incubation with 200ngml
1 anti-Fas IgM for 4h. PARP
was also probed to determine the purity of the fractions. (B) DU 145 cells
were treated for 4h with 200ngml
1 anti-Fas IgM or left untreated. Cells
were lysed gently and DAXX was immunoprecipitated as described in the
Materials and Methods section. Immunoprecipitated complexes and 5%
whole-cell extract from untreated DU 145 cells were subsequently
analysed for HSP27 expression by Western blot. DAXX was probed to
determine equal protein loading. (C) DU 145 cells were stained with
Annexin V–FITC and PI to determine the extent of apoptosis following
incubation for 24h with 5mM SB203580 and 200ngml
1 anti-Fas IgM. Error
bars represent the standard deviation from the mean for three
independent experiments.
Anti-Fas IgM −− ++
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B
Figure 4 Inhibition of caspase activity with z-VAD-fmk completely
abrogates JNK activation in Jurkat cells. (A) DU 145 cells and Jurkat cells
were incubated with 25mM z-VAD-fmk and 200ngml
1 anti-Fas IgM for
4h as outlined above. Cell lysates were subsequently probed for caspase-8
expression and cleavage. Cleavage of procaspase-8 into intermediary P41/
P43 and active P18 caspase-8 subunits was only evident in Jurkat cells
incubated with 200ngml
1 anti-Fas IgM alone. Actin was also probed to
assess equal protein loading. (B) DU 145 cells and Jurkat cells were
incubated with 25mM z-VAD-fmk and 200ngml
1 anti-Fas IgM for 4h.
Phosphorylation of JNK was assessed in cell lysates by Western blot. The
total JNK expression was also assessed to demonstrate equal protein
loading.
+ − − − + + + −
DU 145 DU 145 Jurkat Jurkat
anti-Fas IgM
FADD
Caspase−8 
P41/P43
5% WCE IP FADD
Figure 5 Interaction between FADD and caspase-8 is defective in DU
145 cells. FADD was immunoprecipitated from DU 145 and Jurkat cells
before and after incubation with 200ngml
1 anti-Fas IgM. The samples
were probed for caspase-8 and FADD expression by Western blot. The
endogenous expression of FADD and caspase-8 in 5% whole-cell extracts
was also determined.
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mediated JNK activation was the predominant pathway in Jurkat
cells, at least after 4h. It is possible that caspase-8-independent
JNK activation can also occur here, but progresses more slowly.
In light of our data, defective DISC formation following Fas
receptor activation appeared to be the mechanism by which DU
145 cells were resistant to Fas-mediated apoptosis. We immuno-
precipitated FADD, the adaptor protein required for caspase-8
recruitment to Fas receptor, to determine the extent of interactions
between FADD and caspase-8 in DU 145 cells and Jurkat cells
before and after Fas stimulation. Although DU 145 cells appear to
express higher levels of FADD than Jurkat cells, no interaction
between FADD and caspase-8 was evident before or after Fas
receptor stimulation. By contrast, caspase-8 was found to
immunoprecipitate with FADD in both untreated and anti-Fas
IgM-treated Jurkat cells. Increased caspase-8 in anti-Fas IgM-
treated Jurkat cell immunoprecipitates was consistently observed
and this is probably due to stable interactions between FADD and
caspase-8 in Fas receptor aggregates.
Numerous Fas receptor and FADD interacting proteins have
been identified and a number of these have been shown to regulate
DISC formation following Fas receptor engagement with Fas ligand
and Fas-activating antibodies. These include FAP-1, FAF-1,
FLASH, HIPK3 and PKCx (Peter and Krammer, 2003). It is likely
that one or more of these proteins are differentially regulated in
prostate cancer and as a result increase the threshold required for
Fas receptor activation and apoptosis following engagement of Fas
receptor with Fas ligand. Further studies are ongoing with the aim
of identifying these components. It is hoped that by identifying the
dysfunctional elements in Fas receptor-mediated apoptosis in DU
145 cells novel therapeutic targets may be identified for prostate
cancer.
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